(QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Global Clinical Leader
Daiichi Sankyo
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
131 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Canbera Hospital
Garran, New South Wales, Australia
- Westmead Hospital
Westmead, New South Wales, Australia
- the Princess Alexandra Hospital
Brisbane, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- the Queen Elizabeth Hospital
Woodville, South Australia, Australia
- Alfred Hospital
Melbourne, Victoria, Australia
- Zna Stuivenberg
Antwerp, BE, Belgium
- Ucl St Luc
Brussels, BE, Belgium
- Leuven Uz Gasthuisberg
Leuven, BE, Belgium
- University of Alberta Hospital
Edmonton, Alberta, Canada
- Vancouver General Hospital
Vancouver, British Columbia, Canada
- Princess Margaret Cancer Centre Princess Margaret Hospital
Toronto, Ontario, Canada
- Klinička Bolinca Merkur
Zagreb, Croatia
- Kliničko Bolnički Centar Zagreb
Zagreb, Croatia
- Fakultni Nemocnice Brno
Brno, Czechia
- Fakultni Nemocnice Hradec Kralove
Hradec Králové, Czechia
- Fakultni Nemocnice Olomouc
Olomouc, Czechia
- Chu de Caen
Caen, France
- Centre Hospitalier Universitaire Grenoble Hopital Michalon
Grenoble, France
- Centre Hospitalier de Versailles
Le Chesnay, France
- Hopital de la Conception
Marseille, France
- Centre Hospitalier Universitaire Nantes
Nantes, France
- Hopital Saint-Antoine
Paris, France
- Hôpital Saint Louis
Paris, France
- Hopital Haut Leveque Centre Francois Magendie
Pessac, France
- Centre Henri-Becquerel
Rouen, France
- Centre Hospitalier Universitaire Purpan
Toulouse, France
- Charité Campus Virchow Klinikum
Berlin, Germany
- Charité Universitätsmedizin Berlin
Berlin, Germany
- Klinikum Braunschweig
Braunschweig, Germany
- Universitatsklinikum Dresden
Dresden, Germany
- Klinikum Der Johann Wolfgang-Goethe-Universität
Frankfurt, Germany
- Universitätsklinikum Halle
Halle, Germany
- Medizinische Hochschule Hannover
Hanover, Germany
- Uniklinik Heidelberg Medizinische Klinik Und Poliklinik V
Heidelberg, Germany
- Universitätsklinikum Jena
Jena, Germany
- Universitätsklinikum Leipzig
Leipzig, Germany
- University Mainz
Mainz, Germany
- Universitätsklinikum Giessen Und Marburg Gmbh
Marburg, Germany
- Lmu München Klinikum Großhadern
München, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2014
- Primary completion
- 22 Feb 2018
- Completion
- 8 Sept 2020
- Last update posted
- 24 Feb 2021
- Registered enrollment
- 367
- Registry id
- NCT02039726
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.